| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |